Literature DB >> 18543077

Brain banks: benefits, limitations and cautions concerning the use of post-mortem brain tissue for molecular studies.

Isidre Ferrer1, Anna Martinez, Susana Boluda, Piero Parchi, Marta Barrachina.   

Abstract

Brain banks are facilities providing an interface between generous donation of nervous tissues and research laboratories devoted to increase our understanding of the diseases of the nervous system, discover new diagnostic targets, and develop new strategies. Considering this crucial role, it is important to learn about the suitabilities, limitations and proper handling of individual brain samples for particular studies. Several factors may interfere with preservation of DNA, RNA, proteins and lipids, and, therefore, special care must be taken first to detect sub-optimally preserved tissues and second to provide adequate material for each specific purpose. Basic aspects related with DNA, RNA and protein preservation include agonal state, post-mortem delay, temperature of storage and procedures of tissue preservation. Examination of DNA and RNA preservation is best done by using bioanalyzer technologies instead of less sensitive methods such as agarose gels. Adequate RNA preservation is mandatory in RNA microarray studies and adequate controls are necessary for proper PCR validation. Like for RNA, the preservation of proteins is not homogeneous since some molecules are more vulnerable than others. This aspect is crucial in the study of proteins including expression levels and possible post-translational modifications. Similarly, the reliability of functional and enzymatic studies in human post-mortem brain largely depends on protein preservation. Much less is known about other aspects, such as the effects of putative deleterious factors on epigenetic events such as methylation of CpGs in gene promoters, nucleosome preservation, histone modifications, and conservation of microRNA species. Most brains are appropriate for morphological approaches but not all brains are useful for certain biochemical and molecular studies.

Entities:  

Mesh:

Year:  2008        PMID: 18543077     DOI: 10.1007/s10561-008-9077-0

Source DB:  PubMed          Journal:  Cell Tissue Bank        ISSN: 1389-9333            Impact factor:   1.522


  45 in total

Review 1.  Glutamatergic postsynaptic density protein dysfunctions in synaptic plasticity and dendritic spines morphology: relevance to schizophrenia and other behavioral disorders pathophysiology, and implications for novel therapeutic approaches.

Authors:  Andrea de Bartolomeis; Gianmarco Latte; Carmine Tomasetti; Felice Iasevoli
Journal:  Mol Neurobiol       Date:  2013-09-03       Impact factor: 5.590

2.  The workflow from post-mortem human brain sampling to cell microdissection: a Brain Net Europe study.

Authors:  David Meyronet; Aline Dorey; Patrick Massoma; Catherine Rey; Eudeline Alix; Karen Silva; Corinne Perrin; Isabelle Quadrio; Armand Perret-Liaudet; Nathalie Streichenberger; Nicole Thomasset; Jérôme Honnorat; Thomas Arzberger; Hans Kretzschmar
Journal:  J Neural Transm (Vienna)       Date:  2015-05-16       Impact factor: 3.575

3.  Evaluation of Post-Mortem Effects on Global Brain DNA Methylation and Hydroxymethylation.

Authors:  Louise K Sjöholm; Yusuf Ransome; Tomas J Ekström; Oskar Karlsson
Journal:  Basic Clin Pharmacol Toxicol       Date:  2017-11-13       Impact factor: 4.080

4.  Altered mechanisms of protein synthesis in frontal cortex in Alzheimer disease and a mouse model.

Authors:  Paula Garcia-Esparcia; Georgios Sideris-Lampretsas; Karina Hernandez-Ortega; Oriol Grau-Rivera; Theodoros Sklaviadis; Ellen Gelpi; Isidro Ferrer
Journal:  Am J Neurodegener Dis       Date:  2017-06-15

Review 5.  Selection of controls in the study of human neurodegenerative diseases in old age.

Authors:  I Ferrer
Journal:  J Neural Transm (Vienna)       Date:  2014-08-12       Impact factor: 3.575

6.  The use of museum specimens with high-throughput DNA sequencers.

Authors:  Andrew S Burrell; Todd R Disotell; Christina M Bergey
Journal:  J Hum Evol       Date:  2014-12-18       Impact factor: 3.895

7.  Increased 5-methylcytosine and decreased 5-hydroxymethylcytosine levels are associated with reduced striatal A2AR levels in Huntington's disease.

Authors:  Izaskun Villar-Menéndez; Marta Blanch; Shiraz Tyebji; Thais Pereira-Veiga; José Luis Albasanz; Mairena Martín; Isidre Ferrer; Esther Pérez-Navarro; Marta Barrachina
Journal:  Neuromolecular Med       Date:  2013-02-06       Impact factor: 3.843

8.  Reduced striatal ecto-nucleotidase activity in schizophrenia patients supports the "adenosine hypothesis".

Authors:  Elisabet Aliagas; Izaskun Villar-Menéndez; Jean Sévigny; Mercedes Roca; Miriam Romeu; Isidre Ferrer; Mireia Martín-Satué; Marta Barrachina
Journal:  Purinergic Signal       Date:  2013-06-16       Impact factor: 3.765

9.  Cell death and learning impairment in mice caused by in vitro modified pro-NGF can be related to its increased oxidative modifications in Alzheimer disease.

Authors:  Anton Kichev; Ekaterina V Ilieva; Gerard Piñol-Ripoll; Petar Podlesniy; Isidro Ferrer; Manuel Portero-Otín; Reinald Pamplona; Carme Espinet
Journal:  Am J Pathol       Date:  2009-11-05       Impact factor: 4.307

10.  pH measurement as quality control on human post mortem brain tissue: a study of the BrainNet Europe consortium.

Authors:  C M Monoranu; M Apfelbacher; E Grünblatt; B Puppe; I Alafuzoff; I Ferrer; S Al-Saraj; K Keyvani; A Schmitt; P Falkai; J Schittenhelm; G Halliday; J Kril; C Harper; C McLean; P Riederer; W Roggendorf
Journal:  Neuropathol Appl Neurobiol       Date:  2009-06       Impact factor: 8.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.